186 related articles for article (PubMed ID: 31983646)
21. [Impact of motor and non-motor symptoms on the direct costs of Parkinson's disease].
Cubo E; Martínez Martin P; González M; Frades B;
Neurologia; 2009; 24(1):15-23. PubMed ID: 19003550
[TBL] [Abstract][Full Text] [Related]
22. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson's disease.
Lezcano E; Gómez-Esteban JC; Tijero B; Bilbao G; Lambarri I; Rodriguez O; Villoria R; Dolado A; Berganzo K; Molano A; de Gopegui ER; Pomposo I; Gabilondo I; Zarranz JJ
J Neurol; 2016 May; 263(5):895-905. PubMed ID: 26964542
[TBL] [Abstract][Full Text] [Related]
23. The Effect of Frailty Syndrome on the Quality of Life of Individuals with Parkinson's Disease: A Pilot Observational and Multicenter Study on the Polish Population.
Pytel A; Beszlej JA; Biercewicz M; Roszmann A; Krówczyńska D; Kołtuniuk A
Int J Environ Res Public Health; 2022 Nov; 19(22):. PubMed ID: 36429942
[TBL] [Abstract][Full Text] [Related]
24. Quality of Life and Caregivers' Burden of Parkinson's Disease.
Rajiah K; Maharajan MK; Yeen SJ; Lew S
Neuroepidemiology; 2017; 48(3-4):131-137. PubMed ID: 28728161
[TBL] [Abstract][Full Text] [Related]
25. Quality of life and resource utilization-Swedish data from the Care of Late-Stage Parkinsonism (CLaSP) study.
M Norlin J; Hjalte F; Kruse C; Dodel R; Rosqvist K; Odin P
Acta Neurol Scand; 2022 Jun; 145(6):743-752. PubMed ID: 35312034
[TBL] [Abstract][Full Text] [Related]
26. Quality of life and costs in Parkinson's disease: a cross sectional study in Hungary.
Tamás G; Gulácsi L; Bereczki D; Baji P; Takáts A; Brodszky V; Péntek M
PLoS One; 2014; 9(9):e107704. PubMed ID: 25229404
[TBL] [Abstract][Full Text] [Related]
27. Long-term outcomes of deep brain stimulation in severe Parkinson's disease utilizing UPDRS III and modified Hoehn and Yahr as a severity scale.
Kahn L; Mathkour M; Lee SX; Gouveia EE; Hanna JA; Garces J; Scullen T; McCormack E; Riffle J; Glynn R; Houghton D; Lea G; Biro EE; Bui CJ; Sulaiman OA; Smith RD
Clin Neurol Neurosurg; 2019 Apr; 179():67-73. PubMed ID: 30851616
[TBL] [Abstract][Full Text] [Related]
28. Longitudinal metric properties of disability rating scales for Parkinson's disease.
Martinez-Martin P; Prieto L; Forjaz MJ
Value Health; 2006; 9(6):386-93. PubMed ID: 17076869
[TBL] [Abstract][Full Text] [Related]
29. The current and projected economic burden of Parkinson's disease in the United States.
Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
[TBL] [Abstract][Full Text] [Related]
30. Costs of illness in a Russian cohort of patients with Parkinson's disease.
Winter Y; von Campenhausen S; Popov G; Reese JP; Klotsche J; Bötzel K; Gusev E; Oertel WH; Dodel R; Guekht A
Pharmacoeconomics; 2009; 27(7):571-84. PubMed ID: 19663528
[TBL] [Abstract][Full Text] [Related]
31. Validating the Berg Balance Scale for patients with Parkinson's disease: a key to rehabilitation evaluation.
Qutubuddin AA; Pegg PO; Cifu DX; Brown R; McNamee S; Carne W
Arch Phys Med Rehabil; 2005 Apr; 86(4):789-92. PubMed ID: 15827933
[TBL] [Abstract][Full Text] [Related]
32. The cost-effectiveness of specialized nursing interventions for people with Parkinson's disease: the NICE-PD study protocol for a randomized controlled clinical trial.
Radder DLM; Lennaerts HH; Vermeulen H; van Asseldonk T; Delnooz CCS; Hagen RH; Munneke M; Bloem BR; de Vries NM
Trials; 2020 Jan; 21(1):88. PubMed ID: 31941538
[TBL] [Abstract][Full Text] [Related]
33. The path linking disease severity and cognitive function with quality of life in Parkinson's disease: the mediating effect of activities of daily living and depression.
He Y; Tian Y; Han H; Cui J; Ge X; Qin Y; Luo Y; Bai W; Yu H
Health Qual Life Outcomes; 2021 Mar; 19(1):92. PubMed ID: 33731129
[TBL] [Abstract][Full Text] [Related]
34. [Social and economic cost of L-Dopa-induced dyskinesias in patients with Parkinson's disease].
Maurel F; Lilliu H; Le Pen C
Rev Neurol (Paris); 2001 May; 157(5):507-14. PubMed ID: 11438770
[TBL] [Abstract][Full Text] [Related]
35. The impact of Parkinson's disease severity on performance of activities of daily living: an observational study.
Alegre-Ayala J; Vela L; Fernández-Vázquez D; Navarro-López V; Macías-Macías Y; Cano-de-la-Cuerda R
Rev Neurol; 2023 Apr; 76(8):249-255. PubMed ID: 37046393
[TBL] [Abstract][Full Text] [Related]
36. Health-related quality-of-life, work productivity, and economic burden among patients with Parkinson's disease in Japan.
Yamabe K; Liebert R; Flores N; Pashos C
J Med Econ; 2018 Dec; 21(12):1206-1212. PubMed ID: 30200795
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
38. Effects of robotic treadmill training on functional mobility, walking capacity, motor symptoms and quality of life in ambulatory patients with Parkinson's disease: a preliminary prospective longitudinal study.
Paker N; Bugdayci D; Goksenoglu G; Sen A; Kesiktas N
NeuroRehabilitation; 2013; 33(2):323-8. PubMed ID: 23949054
[TBL] [Abstract][Full Text] [Related]
39. The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.
Schrag A; Selai C; Jahanshahi M; Quinn NP
J Neurol Neurosurg Psychiatry; 2000 Jul; 69(1):67-73. PubMed ID: 10864606
[TBL] [Abstract][Full Text] [Related]
40. Burden and health-related quality of life among caregivers of Brazilian Parkinson's disease patients.
Carod-Artal FJ; Mesquita HM; Ziomkowski S; Martinez-Martin P
Parkinsonism Relat Disord; 2013 Nov; 19(11):943-8. PubMed ID: 23831481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
